Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Cash from Investing Activities: 2023-2024

Historic Cash from Investing Activities for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$30.6 million.

  • Zenas BioPharma's Cash from Investing Activities rose 249.64% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$162.3 million, marking a year-over-year change of. This contributed to the annual value of -$30.6 million for FY2024, which is 179617.65% down from last year.
  • Per Zenas BioPharma's latest filing, its Cash from Investing Activities stood at -$30.6 million for FY2024, which was down 179,617.65% from -$17,000 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Cash from Investing Activities ranged from a high of -$17,000 in FY2023 and a low of -$30.6 million during FY2024.
  • Over the past 2 years, Zenas BioPharma's median Cash from Investing Activities value was -$15.3 million (recorded in 2023), while the average stood at -$15.3 million.
  • Data for Zenas BioPharma's Cash from Investing Activities shows a maximum YoY crashed of 179,617.65% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Cash from Investing Activities stood at -$17,000 in 2023, then plummeted by 179,617.65% to -$30.6 million in 2024.